首页> 外文期刊>Cancer control : >Amyloid A amyloidosis secondary to hyper IgD syndrome and response to IL-1 blockage therapy
【24h】

Amyloid A amyloidosis secondary to hyper IgD syndrome and response to IL-1 blockage therapy

机译:淀粉样变性继发于高IgD综合征和对IL-1阻断疗法的反应的淀粉样变性

获取原文
获取外文期刊封面目录资料

摘要

A 62-year-old woman with a history of genetically confirmed hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS) was admitted because of chronic diarrhoea. During admission she developed a rapidly progressive nephrotic syndrome. Reactive amyloid A (AA) amyloidosis was confirmed after colonic and renal biopsy which showed deposition of amyloid. After initial treatment with high-dosed corticosteroids, therapy was switched to anakinra, an IL-1 receptor antagonist, but her symptoms persisted. After cessation of anakinra, a marked exacerbation of the intestinal symptoms was noted. Nine months after the initial diagnosis of reactive amyloidosis without any amelioration of the symptoms and a decreasing quality of life, our patient declined further treatment and died soon after. This case demonstrates that AA amyloidosis does occur in patients with HIDS and can present with intestinal symptoms and proteinuria. Once amyloidosis is diagnosed the goal of treatment is to prevent further complications. In this case report we give an overview of previous cases with amyloidosis complicating HIDS with the treatments received and propose a step-up treatment plan for future cases.
机译:因慢性腹泻而入院,有62名经遗传学证实为高免疫球蛋白血症D和周期性发热综合征(HIDS)的女性。入院期间她发展为快速进行性肾病综合征。结肠和肾脏活检显示淀粉样蛋白沉积后,证实反应性淀粉样蛋白A(AA)淀粉样变性。在开始使用高剂量的皮质类固醇激素治疗后,治疗转向了IL-1受体拮抗剂anakinra,但她的症状持续存在。停止Anakinra后,注意到肠道症状明显恶化。最初诊断为反应性淀粉样变性9个月后,症状没有改善,生活质量下降,我们的患者拒绝了进一步治疗,不久后死亡。该病例表明,AA淀粉样变性确实发生在HIDS患者中,并可能出现肠道症状和蛋白尿。一旦诊断出淀粉样变性,治疗的目标就是防止进一步的并发症。在此病例报告中,我们概述了以前患有淀粉样变性病的病例,这些病例使HIDS与所接受的治疗并发,并提出了针对未来病例的逐步治疗计划。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号